David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Strengthening capabilities in Peptide Therapeutics and CDMO services
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subscribe To Our Newsletter & Stay Updated